Dimethyl fumarate Polpharma Европейски съюз - словашки - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetylfumarát - roztrúsená skleróza, recidivujúce-odosielajúcej - imunosupresíva - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimtruzic 240 mg Словакия - словашки - ŠÚKL (Štátny ústav pre kontrolu liečiv)

dimtruzic 240 mg

sandoz pharmaceuticals d.d., slovinsko - dimetyl-fumarát - 59 - immunopraeparata

Dimtruzic 120 mg Словакия - словашки - ŠÚKL (Štátny ústav pre kontrolu liečiv)

dimtruzic 120 mg

sandoz pharmaceuticals d.d., slovinsko - dimetyl-fumarát - 59 - immunopraeparata

Dimethyl fumarate Teva Европейски съюз - словашки - EMA (European Medicines Agency)

dimethyl fumarate teva

teva gmbh - dimetylfumarát - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresíva - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Accord Европейски съюз - словашки - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - dimetylfumarát - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresíva - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).